Glucosteril (Glucose Monohydrate)

Glucosteril is employed in medical settings where immediate glucose provision and fluid balance are needed.

• Treatment of acute hypoglycemia in adults and children
• Component of parenteral nutrition regimens
• Fluid and electrolyte replenishment during dehydration
• Intra‑operative glucose support for surgical patients
• Maintenance of glucose levels in neonatal intensive care
• Emergency care for patients with low blood glucose due to trauma or illness

Glucosteril may be associated with both mild and more serious adverse reactions.

Common

• Mild hyperglycemia
• Local irritation or pain at the intravenous site
• Transient peripheral edema
• Nausea or mild gastrointestinal discomfort
• Temporary increase in serum osmolality
• Mild electrolyte shifts (e.g., potassium)

Serious

• Severe hyperglycemia requiring medical intervention
• Significant electrolyte imbalance (e.g., severe hypokalemia)
• Anaphylactic or severe allergic reaction
• Volume overload leading to pulmonary edema
• Acute renal dysfunction in susceptible patients
• Life‑threatening hyperosmolar state

Safety considerations are essential when administering Glucosteril.

• Monitor blood glucose levels frequently during infusion
• Assess fluid status and avoid excessive volume administration
• Use caution in patients with renal, cardiac, or hepatic impairment
• Adjust dosing for pediatric or neonatal patients under professional guidance
• Verify compatibility with other intravenous solutions and catheters
• Review pregnancy and lactation status before use
• Discontinue if signs of severe hyperglycemia or allergic reaction appear

Glucosteril can interact with other medications and solutions administered intravenously.

Avoid

• Co‑administration of additional high‑dose dextrose or glucose solutions
• Insulin overdose or mismatched insulin dosing
• Medications that cause marked hypokalemia (e.g., high‑dose diuretics)
• Hyperosmolar agents that may exacerbate fluid shifts

Use with caution

• Loop or thiazide diuretics affecting electrolyte balance
• Beta‑blockers that may mask hypoglycemia symptoms
• Corticosteroids that increase glucose production
• Vasopressors influencing circulatory dynamics
• Other intravenous fluids requiring careful volume management